Role of Akt signaling in vascular homeostasis and angiogenesis

Circulation Research

Volumn 90, Issue 12, 2002, Pages 1243-1250

  Shiojima, Ichiro ^a   Walsh, Kenneth ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Angiogenesis; Endothelial cells; Endothelial nitric oxide synthase; Statins

Indexed keywords

ANGIOPOIETIN 1; BINDING PROTEIN; CAVEOLIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; DECORIN; ESTROGEN; FLICE INHIBITORY PROTEIN; FOCAL ADHESION KINASE; GLYCOGEN SYNTHASE KINASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PLATELET DERIVED GROWTH FACTOR; PLECKSTRIN; PROTEIN BAD; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN MDM2; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; S6 KINASE; SCATTER FACTOR; SOMATOMEDIN C; SPHINGOSINE 1 PHOSPHATE; TRANSCRIPTION FACTOR E2F; UNINDEXED DRUG; VASCULOTROPIN; WORTMANNIN;

ANGIOGENESIS; APOPTOSIS; CELL MIGRATION; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; GLUCOSE METABOLISM; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; STROKE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIVISION; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 0037188941     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000022200.71892.9F     Document Type: Review

References (145)

1. Mechanisms of angiogenesis and arteriogenesis
2. Vascular-specific growth factors and blood vessel formation
3. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
4. Therapeutic angiogenesis for ischemic cardiovascular disease
5. Molecular cloning of the Akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma
6. A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region
7. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families
8. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily
9. Cellular survival: A play in three Akts
10. Pkb/Akt, functional insights from genetic models
11. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene
12. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin
13. A human protein kinase Bγ with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain
14. Akt signaling: Linking membrane events to life and death decisions
15. Mechanisms and consequences of activation of protein kinase B/Akt
16. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
17. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils
18. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2
19. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
20. Myocardial Akt activation and gender: Increased nuclear activity in females versus males
21. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors
22. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
23. The protein kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
24. Regulation of neuronal survival by the serine-threonine protein kinase Akt
25. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival
26. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
27. Genetic analysis of protein kinase B (AKT) in Drosophila
28. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene
29. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
30. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
31. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
32. Direct control of the Forkhead transcription factor AFX by protein kinase B
33. Negative regulation of the forkhead transcription factor FKHR by Akt
34. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
35. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
36. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts
37. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
38. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
39. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit
40. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
41. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
42. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells
43. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism
44. Glycogen synthase kinase-3 couples Akt-dependent signaling to the regulation of p21Cip1 degradation
45. 4E-BP1 and S6K1: Translational integration sites for nutritional and hormonal information in muscle
46. 3-Phosphoinosifide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
47. Phosphorylation and activation of p70s6k by PDK1
48. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
49. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: Requirement for Flk-1/KDR activation
50. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner
51. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
52. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway
53. Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells
54. The Akt kinase signals directly to endothelial nitric oxide synthase
55. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase, differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells
56. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phospho-inositide 3-kinase pathway in endothelial cells
57. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, Stat3, and Akt in endothelial cells
58. Decorin mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1)
59. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: Involvement in suppression of apoptosis
60. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
61. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phoshorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway
62. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase
63. 3 for angiogenesis
64. Anoikis mechanisms
65. Integrin signaling
66. Integrin and growth factor receptor crosstalk
67. The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis
68. A mechanism for modulation of cellular responses to VEGF: Activation of the integrins
69. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP)
70. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells
71. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
72. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance
73. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium
74. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
75. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
76. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
77. Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: Role of protein kinase A
78. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo
79. Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion
80. Adrenomedullin induces endothelium-dependent vasorelaxation via the Phosphatidylinositol 3-Kinase/Akt-dependent pathway in rat aorta
81. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site
82. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling
83. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae
84. Endothelial nitric oxide synthase targeting to caveolae: Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells
85. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity
86. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation
87. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
88. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes: Implications for the autonomic regulation of heart rate
89. Cellular regulation of endothelial nitric oxide synthase
90. Dynamic activation of endothelial nitric oxide synthase by Hsp90
91. Modulation of Akt kinase activity by binding to Hsp90
92. 2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells
93. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins
94. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release
95. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt
96. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
97. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration
98. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate
99. Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration
100. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway
101. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium
102. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis
103. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
104. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction
105. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration
106. Cell migration: A physically integrated molecular process
107. Rho proteins, PI 3-kinases, and monocyte/macrophage motility
108. Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system
109. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement
110. Rho family GTPases regulate VEGF-stimulated endothelial cell motility
111. Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1
112. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis
113. Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells
114. Rac and phosphatidylinositol 3-kinase regulate the protein kinase B in Fc epsilon RI signaling in RBL 2H3 mast cells
115. The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase
116. p21-activated protein kinase: A crucial component of morphological signaling?
117. Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase through the regulation of PAKa
118. The Akt proto-oncogene links Ras to Pak and cell survival signals
119. Current perspectives on statins
120. The effect of cholesterol-lowering and antioxidant therapy on endothelium dependent coronary vasomotion
121. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
122. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
123. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
124. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts
125. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia
126. Statins have biphasic effects on angiogenesis
127. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
128. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells
129. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
130. Safety profiles for the HMG-CoA reductase inhibitors: Treatment and trust
131. Double-edged role of statins in angiogenesis signaling
132. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
133. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: Contribution to its anti-angiogenic effect
134. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models
135. Pravastatin: An antithrombotic effect independent of the cholesterol-lowering effect
136. An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression
137. Angiopoietin-I negatively regulates expression and activity of tissue factor in endothelial cells
138. Tissue factor and coronary artery disease
139. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB
140. The genetic control of organ growth: Insights from Drosophila
141. Role of insulin receptors and IGF receptors in growth and development
142. Akt1/pkbα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice
143. Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training
144. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function
145. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth